Promissory Note Receivable (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Aug. 29, 2024 |
Oct. 01, 2020 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Jun. 30, 2024 |
Jun. 19, 2023 |
|
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
| Promissory note receivable, current | $ 713,000 | |||||||
| Promissory note receivable, non-current | $ 1,115,000 | $ 1,115,000 | 1,081,000 | |||||
| Interest income | 112,000 | $ 42,000 | 286,000 | $ 97,000 | ||||
| Safi Biosolutions | Promissory Note | ||||||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
| Promissory note receivable, current | 713,000 | |||||||
| Promissory note receivable, non-current | 1,115,000 | 1,115,000 | $ 1,081,000 | |||||
| Promissory note receivable, net | $ 1,500,000 | |||||||
| Interest payments on notes receivable | $ 713,000 | |||||||
| Payments on notes receivable (amounts applied against principal balance) | $ 419,000 | |||||||
| Interest rate | 5.00% | |||||||
| Interest rate for first one year extension | 7.00% | |||||||
| Interest rate for second one year extension | 9.00% | |||||||
| Interest income | $ 14,000 | $ 22,000 | $ 33,000 | $ 44,000 | ||||
| X | ||||||||||
- Definition Percentage of fixed rate of interest on notes. No definition available.
|
| X | ||||||||||
- Definition Percentage of rate of interest on notes receivable for first one year extension. No definition available.
|
| X | ||||||||||
- Definition Percentage of rate of interest on notes receivable for second one year extension. No definition available.
|
| X | ||||||||||
- Definition Payments received for interest owed to the Company for interest accrued on notes issued. No definition available.
|
| X | ||||||||||
- Definition Payments received for notes issued, amounts applied directly to principal balance. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of financing receivable, classified as noncurrent. No definition available.
|
| X | ||||||||||
- Definition Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|